Koers Chengdu Kanghong Pharmaceutical Group Co., Ltd
Aandelen
002773
CNE1000020C4
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21 CNY | +1,50% | +18,78% | +13,88% |
Omzet 2024 * | 4,3 mld. 594 mln. 555 mln. | Omzet 2025 * | 4,95 mld. 683 mln. 638 mln. | Marktkapitalisatie | 19,31 mld. 2,67 mld. 2,49 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,22 mld. 168 mln. 157 mln. | Nettowinst (verlies) 2025 * | 1,46 mld. 202 mln. 188 mln. | EV/omzet 2024 * | 4,49 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,9 x |
K/w-verhouding 2024 * |
15,9
x | K/w-verhouding 2025 * |
13,2
x | Werknemers | 4.289 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 28,62% |
1 dag | +1,50% | ||
1 week | +18,78% | ||
Lopende maand | +21,25% | ||
1 maand | +21,25% | ||
3 maanden | +30,43% | ||
6 maanden | +26,13% | ||
Lopend jaar | +13,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jian Jun Zhong
DFI | Director of Finance/CFO | 57 | - |
Xiao Ke
PSD | President | 41 | 01-01-12 |
Jin Qun Yin
BRD | Director/Board Member | 52 | 21-06-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Rong Zhong
BRD | Director/Board Member | 67 | 01-01-12 |
Zun Hong Ke
CHM | Chairman | 70 | 01-01-98 |
Xiao Ke
PSD | President | 41 | 01-01-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,43% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
29-04-24 | 21 | +1,50% | 23 896 980 |
26-04-24 | 20,69 | +2,78% | 42 169 570 |
25-04-24 | 20,13 | +10,00% | 30 904 670 |
24-04-24 | 18,3 | +2,92% | 9 189 057 |
23-04-24 | 17,78 | +0,57% | 5 851 306 |
slotkoers Shenzhen S.E., 29 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,88% | 2,67 mld. | |
+26,47% | 664 mld. | |
+25,70% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+13,42% | 234 mld. | |
+4,71% | 199 mld. | |
-10,10% | 196 mld. | |
-4,04% | 148 mld. |